Sarcoidosis is a systemic granulomatous disease of unknown origin, characte
rized in affected organs by an accumulation of activated T lymphocytes and
macrophages. Musculoskeletal manifestations of sarcoidosis include acute an
d chronic arthritis and muscular and osseous sarcoidosis. In certain popula
tions, acute sarcoidosis often presents with constitutional symptoms, polya
rthritis and erythema nodosum (Lofgren's syndrome). Erythema nodosum, often
with joint symptoms, also occurs in association with several other conditi
ons including infections, medications and other underlying diseases. The di
agnosis of sarcoidosis should be based on a tissue biopsy, but a patient wi
th typical Lofgren's syndrome may not require biopsy proof. Among the long
list of biochemical markers that have been suggested as aids for diagnosis
and monitoring of sarcoidosis, calcium in serum and urine and angiotensin-c
onverting enzyme in serum are well-established clinical tools. Serum angiot
ensin-converting enzyme can be used for monitoring disease activity in the
individual patient, but because of lack of sensitivity and specificity its
diagnostic value is rather low. Non-steroidal anti-inflammatory agents usua
lly effectively alleviate acute sarcoid arthritis and joint symptoms associ
ated with erythema nodosum. In severe acute arthritis and in chronic arthri
tis, corticosteroids may be required to control the symptoms. In patients r
equiring persistent corticosteroid therapy, antimalarial agents and methotr
exate constitute therapeutic alternatives.